Last reviewed · How we verify
NCT05966077: EVAREST3
Impact of Sending an Sms on the Rate of Telephone Responses of Subjects Contacted 3 Months After the Suicidal Act
NA trial testing IMPACT OF SENDING AN SMS in Suicide, Attempted in 250 participants. Status unknown.
1 June 2024
Quick facts
| Lead sponsor | Centre Psychothérapique de Nancy |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 250 |
| Start date | 1 June 2024 |
| Primary completion | 1 June 2024 |
| Estimated completion | 1 June 2025 |
Drugs / interventions tested
- IMPACT OF SENDING AN SMS
Conditions studied
- Suicide, Attempted — all drugs for Suicide, Attempted →
Sponsor
Centre Psychothérapique de Nancy
Who can join
18 and older, any sex, with Suicide, Attempted. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this controlled, randomized, monocentric study is to compare the response rate of the call at 3 months of the groups with or without short message service (SMS) 48 hours before, for the subjects having benefited from the device "VigilanS Lorraine". The secondary objectives will be to appreciate the satisfaction of the subjects towards the sending of the SMS as well as to compare the delay of suicidal recidivism according to whether the subjects answered or not to the call of evaluation at 3 months of the passage to the act The main question it aims to answer is: What impact, on the rate of successful calls, could sending a text message 48 hours before the 3-month evaluation phone call have on subjects benefiting from the VigilanS device? The participants will be divided into 2 groups: * 1st group: SMS sent 48 hours before the 3-month evaluation call planned in the framework of the "VigilanS Lorraine" program. * 2nd group (control): evaluation call at 3 months planned within the framework of the "VigilanS Lorraine" system, not preceded by an SMS 48 hours before. The desired effect was an increase in the percentage of successful calls at 3 months, allowing for possible evaluations at 3 months in order to identify, evaluate and accompany subjects still in a suicidal crisis and thus avoid a recurrence of the act and thus a suicide.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05966077
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Suicide, Attempted
Currently open trials in the same condition.
- NCT07219355 — Virtual Reality Lethal Means Safety Training · NA · recruiting
- NCT07395752 — Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study · NA · recruiting
- NCT06151158 — Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings · NA · recruiting
- NCT06474221 — Efficacy of EBPSI on Future Suicide Risk Among Adolescent Suicide Attempters · NA · recruiting
- NCT06248268 — Neuropsychological Patterns of Suicide Ideators and Suicide Attempters · recruiting
Other Centre Psychothérapique de Nancy trials
Trials by the same sponsor.
- NCT06532604 — Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder · NA · not yet recruiting
- NCT07499934 — Experience of UHR and PEP Individuals During Mindfulness: a Qualitative Phenomenological Study · NA · recruiting
- NCT06649552 — French Validation of Schizophrenia Proneness Instrument- Child Youth · NA · not yet recruiting
- NCT06361407 — Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia · NA · recruiting
- NCT06330467 — Prevalence of Dissociative Identity Disorder in At-risk Outpatient Groups Reporting Childhood Trauma. · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05966077 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Psychothérapique de Nancy
- Last refreshed: 8 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05966077.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing